Supplementary Figure S3. MIR652-3p modulation and cancer phenotype in cell lines and PDOs
No takes yet. Share an insight, caveat, or question.
Hedayat et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: